James J. Bochnowski
Jim founded Delphi Ventures in 1988. His focus is on medical devices and biotechnology.
Jim began investing in medical companies in 1981 after co-founding Technology Venture Investors, a private venture capital partnership. Since 1984, he has focused exclusively on healthcare investments.
From 1976 to 1980, Jim was with Shugart Associates, a venture-backed disk drive company. As President and CEO, he led Shugart to increasing profitability, with annual revenues growing from $13 million to $200 million. Shugart was acquired by Xerox in 1979.
From 1972 to 1976, Jim was a general partner with Donaldson Lufkin & Jenrette's (DLJ) venture capital arm, the Sprout Capital Group. Prior to that, he served as a securities analyst with DLJ.
Trained as an aerospace engineer at MIT, Jim served as an Army officer and a missile systems engineer with the U.S. Army Missile Intelligence Directorate, serves on the Board of Overseers of the Hoover Institution at Stanford University and is a member of the Harvard School of Public Health's Health Policy and Management Executive Council. Jim was a director of the Western Association of Venture Capital.
- MBA with Distinction, Harvard University Graduate School of Business
- BS Massachusetts Institute of Technology
REPRESENTATIVE INVESTMENTS AND BOARD INVOLVEMENT
- Applied Molecular Evolution, Inc., (AMEV) a.b. Eli Lilly & Co. (LLY)
- Ascent Healthcare Solutions, Inc. a.b. Stryker (SYK)
- Avicenna Systems Corp., a.b. WebMD Corp. (HLTH)
- CollaGenex Pharmaecuticals, Inc. (CGPI) a.b. Galderma Pharma, S.A.
- Elenza, Inc.
- Exogen, Inc. (EXGN) a.b. Smith & Nephew, Inc. (SNS)
- ImmuLogic Pharmaceuticals, Inc. (IMUL)
- Integrated Vascular Systems, Inc. a.b. Abbott Laboratories (ABT)
- Micro Interventional Systems, Inc. a.b. Medtronic, Inc. (MDT)
- MicroVention, Inc. a.b. Terumo Corporation
- Natus Medical, Inc. (BABY)
- PixelOptics, Inc.
- Sequent Medical, Inc.
- Synaptics, Inc. (SYNA)
- SynergEyes, Inc.